Description |
tenascin R |
quiescin sulfhydryl oxidase 1 |
Image |
No pdb structure |
|
Cellular Component |
|
|
Molecular Function |
|
|
Biological Process |
|
|
Pathways |
|
|
Drugs |
|
|
Diseases |
|
|
GWAS |
- 3-month functional outcome in ischaemic stroke (modified Rankin score) ( 30796134)
- Attention deficit hyperactivity disorder ( 30563984)
- Body mass index ( 26426971)
- Corneal astigmatism ( 29422769)
- Disease progression to choroidal neovascularization form in age-related macular degeneration ( 29346644)
- Liver fibrosis in non-alcoholic fatty acid liver disease ( 31311600)
- Telomere length ( 30185882)
- Tonometry ( 17903302)
|
|
Interacting Genes |
16 interacting genes:
ACAN
BCAN
CCDC146
CNTN1
LGALS14
MAGEB4
NCAN
NCK2
NFASC
NTAQ1
POLR3C
PSMA1
PTPRZ1
SIGLEC1
TRIM54
VCAN
|
6 interacting genes:
BEGAIN
CCR1
CCR6
CHRM4
UBE2D2
UBQLN4
|
Entrez ID |
7143 |
5768 |
HPRD ID |
03589 |
06785 |
Ensembl ID |
ENSG00000116147
|
ENSG00000116260
|
Uniprot IDs |
A1L306
Q92752
|
A0A140VKE5
O00391
Q13876
|
PDB IDs |
|
3LLI
3LLK
3Q6O
4IJ3
|
Enriched GO Terms of Interacting Partners? |
|
|
Tagcloud ? |
|
|
Tagcloud (Difference) ? |
|
|
Tagcloud (Intersection) ? |
|